Received Orphan Drug Designation from the FDA, has the familiar bullish divergence breakout pattern leading up to the news, double bottom reversal pattern included
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
